SAMRAT PHARMACHEM
|
The Current P/S Ratio of SAMRAT PHARMACHEM is 0.24.
| Share Price | ₹221.2 | Apr 21,2026 |
| Market Cap | ₹68.6 Cr | |
| Sales-TTM | ₹289.2 Cr | TTM-Standalone Results |
| Price/Sales | 0.24x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of SAMRAT PHARMACHEM
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹68.6 Cr] as on Apr 21,2026
(/) Sales [ ₹289.2 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 0.24x ]
Thus, for SAMRAT PHARMACHEM , the investors are currently willing to pay '0.24 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SAMRAT PHARMACHEM !
The chart below summarizes the trend in P/S Ratio of SAMRAT PHARMACHEM over the last five years.
Historical PS (Price/Sales) ratio chart of SAMRAT PHARMACHEM
PS Ratio Performance Analysis for SAMRAT PHARMACHEM
- SAMRAT PHARMACHEM 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 0.40x.
- SAMRAT PHARMACHEM 's operated at median p/e ratio of 0.37x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SAMRAT PHARMACHEM 's p/e ratio peaked in Mar2022 at 0.68x.
- SAMRAT PHARMACHEM 's p/e ratio hit its five-year low in Mar2021 of 0.23x.
How does SAMRAT PHARMACHEM 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| SAMRAT PHARMACHEM | 289.2 | 0.24 | 68.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.03 | 399,549.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 16.18 | 166,862.0 |
| CIPLA LTD | 28,351.1 | 3.51 | 99,591.5 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 10.98 | 139,912.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 2.94 | 101,891.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.51 | 90,642.6 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.58 | 93,464.0 |
| LUPIN LTD | 26,150.5 | 4.04 | 105,688.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.44 | 80,798.2 |
| ABBOTT INDIA LTD | 6,824.1 | 7.91 | 53,961.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SAMRAT PHARMACHEM 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 0.24x |
| Max industry PS | 16.18x |
| Median industry PS | 4.04x |
| Average industry PS | 5.94x |
You may also like the below Video Courses